Historical Stock Price
ETFs Holding AMGN »    AMGN Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
10/09/2018 $205.75 $208.08 $204.49 $206.00 2.51M
10/10/2018 $205.00 $206.35 $200.77 $201.20 4.15M
10/11/2018 $201.55 $202.96 $192.38 $193.85 4.17M
10/12/2018 $195.62 $198.09 $194.15 $197.39 3.23M
10/15/2018 $196.20 $198.41 $195.00 $195.59 2.05M
Amgen is a global biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co. focuses its research and development on human therapeutics for the treatment of illness primarily in the areas of oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and neuroscience. Co.'s principal products include Enbrel®, Neulasta®, Aranesp®, Prolia®, Sensipar®/Mimpara®, XGEVA®, and EPOGEN®. In addition, Co. markets several other products, including KYPROLIS® (carfilzomib), Vectibix® (panitumumab), Nplate® (romiplostim), Repatha® (evolocumab), BLINCYTO® (blinatumomab), IMLYGIC® (talimogene laherparepvec) and Corlanor® (ivabradine).
AMGN historical stock prices picture
Amgen (AMGN) has the following price history information. Looking back at AMGN historical stock prices for the last five trading days, on October 09, 2018, AMGN opened at $205.75, traded as high as $208.08 and as low as $204.49, and closed at $206.00. Trading volume was a total of 2.51M shares. On October 10, 2018, AMGN opened at $205.00, traded as high as $206.35 and as low as $200.77, and closed at $201.20. Trading volume was a total of 4.15M shares. On October 11, 2018, AMGN opened at $201.55, traded as high as $202.96 and as low as $192.38, and closed at $193.85. Trading volume was a total of 4.17M shares. On October 12, 2018, AMGN opened at $195.62, traded as high as $198.09 and as low as $194.15, and closed at $197.39. Trading volume was a total of 3.23M shares. On October 15, 2018, AMGN opened at $196.20, traded as high as $198.41 and as low as $195.00, and closed at $195.59. Trading volume was a total of 2.05M shares.

AMGN Historical Stock Prices By Date:

AMGN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Amgen shares, starting with a $10,000 purchase of AMGN, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 10/16/2008
End date: 10/15/2018
Start price/share: $50.80
End price/share: $195.59
Starting shares: 196.85
Ending shares: 231.45
Dividends reinvested/share: $22.04
Total return: 352.69%
Average Annual Total Return: 16.30%
Starting investment: $10,000.00
Ending investment: $45,287.34
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/16/2008
End date: 10/15/2018
Start price/share: $50.80
End price/share: $195.59
Dividends collected/share: $22.04
Total return: 328.41%
Average Annual Total Return: 15.66%
Starting investment: $10,000.00
Ending investment: $42,855.34
Years: 10.00
Date Close
10/09/2018$206.00
10/10/2018$201.20
10/11/2018$193.85
10/12/2018$197.39
10/15/2018$195.59
AMGN is categorized under the Healthcare sector; below are some other companies in the same sector:

AMN Historical Stock Prices
AMPE Historical Stock Prices
AMPH Historical Stock Prices
AMRI Historical Stock Prices
AMRN Historical Stock Prices
AMS Historical Stock Prices
AMSG Historical Stock Prices
ANAB Historical Stock Prices
ANAC Historical Stock Prices
ANCI Historical Stock Prices

Also explore: AMGN shares outstanding history

AMGN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.